Prosecution Insights
Last updated: October 02, 2026
Application No. 18/570,920

READY-TO-EAT AND READY-TO-DRINK PRODUCTS

Non-Final OA §103
Filed
Dec 15, 2023
Priority
Jul 01, 2021 — continuation of 17/365,193 +1 more
Examiner
TURNER, FELICIA C
Art Unit
1793
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Givaudan S.A.
OA Round
3 (Non-Final)
26%
Grant Probability
At Risk
3-4
OA Rounds
1y 4m
Est. Remaining
56%
With Interview

Examiner Intelligence

Grants only 26% of cases
26%
Career Allowance Rate
167 granted / 636 resolved
-38.7% vs TC avg
Strong +30% interview lift
Without
With
+30.1%
Interview Lift
resolved cases with interview
Typical timeline
4y 2m
Avg Prosecution
52 currently pending
Career history
700
Total Applications
across all art units

Statute-Specific Performance

§101
1.0%
-39.0% vs TC avg
§103
61.9%
+21.9% vs TC avg
§102
8.8%
-31.2% vs TC avg
§112
24.2%
-15.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 636 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . This office action was written in response to the Applicant’s Remarks filed 9/10/26. Claims 1, 2, 6-9, 11, 19 and 21 are pending and have been examined on the merits. Claims 4 and 20 have been cancelled. Claims 3, 5, 10, 12-18 were previously cancelled. Claim 21 is new. The Examiner notes that prosecution was reopened due to the Bhowmik reference used in the previous rejection of claim 4. Bhowmik was not prior art due to being inventor owned reference published less than one year before the filing date of the invention. Claim Objections Claim 21 is objected to under 37 CFR 1.75 as being a substantial duplicate of claim 1. When two claims in an application are duplicates or else are so close in content that they both cover the same thing, despite a slight difference in wording, it is proper after allowing one claim to object to the other as being a substantial duplicate of the allowed claim. See MPEP § 608.01(m). Withdrawn Rejections The 103(a) rejections of claims 1, 2, 4, 6-9, 11, and 19 over Agayn (WO 2017/126959) and in further view of Bhowmik et al. (WO 2020/157209). The 103(a) rejection of claim 20 is rejected under 35 U.S.C. 103 as being unpatentable over Agayn (WO 2017/126959), Bhowmik et al. (WO 2020/157209) and DeSimone et al. (US 2008/0131556) has been withdrawn due to the cancellation of the claim. Claim Rejections - 35 USC § 103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claims 1, 2, 6-9, 11, 19, and 21 are rejected under 35 U.S.C. 103 as being unpatentable over Molin (US 5,190,755). Regarding Claims 1 and 21: Molin discloses a nutrient composition made by treating cereal with enzymes and by fermentation [abstract]. Molin discloses treating the cereal with amylase (carbohydrase) and protease [abstract]. Molin discloses further fermenting the enzyme treated cereal with L. brevis, L. plantarum, and L. acidophilus [col. 2, lines 54-60]. Molin discloses oat and corn as the cereal [col. 3, lines 1-2]. It is known in the art that at least oats and corn (maize) are gluten free grains and therefore the method would have produced a gluten free product. Molin discloses fermenting for about 20 hours [col. 4, lines 5-9]. Molin discloses enzymatic treatment at 50°C [claim 1]. However, it would have been obvious to one having ordinary skill in the art at the time of the invention to adjust the fermenting time for reducing gluten content, since it has been held that discovering an optimum value of a result effective variable involves only routine skill in the art. In re Boesch, 617 F.2d 272. Regarding Claim 2: Molin discloses as discussed above in claim 1. Molin discloses oat flour [col. 2, lines 61-64]. Regarding Claims 6 and 7: Molin discloses as discussed above in claim 1. Molin discloses treating with an enzyme before fermentation [abstract]. Regarding Claim 9: Molin discloses as discussed above in claim 1. Molin discloses oat [col. 3, lines 1-2]. Regarding Claim 11: Molin discloses as discussed above in claim 1. Molin discloses further fermenting the cereal with L. brevis, L. plantarum, and L. acidophilus [col. 2, lines 54-60]. Regarding Claim 19: Molin discloses as discussed above in claim 1. Molin discloses mixing oat flour and water with the enzymes [abstract; col. 2, lines 61-64]. This is essentially oat milk as it is known in the art to make oat milk from ground oats, and water and amylase. Claims 1, 2, 6-9, 11, 19, and 21 are rejected under 35 U.S.C. 103 as being unpatentable over Agayn (WO 2017/126959) and in further view of Mok et al. KR 930005199 June 1993. Regarding Claims 1 and 21: Agayn discloses a method of treating grains including rice, oats, maize, barley, millet, fonio [pg. 5, lines 10-15; pg. 6, lines 1-10]. Agayn discloses that the grain is used to make a ready to eat food or drink (yogurt) [pg. 8, lines 22-30; pg. 9, lines 1-3; pg. 45, lines 16-29; claim 8]. Agayn discloses fermenting the grains with lactic acid bacteria such as Lactobacillus paracasei, Lactobacillus casei, Lactobacillus rhamnosus, Lactobacillus bulgaricus, Lactobacillus delbrueckii subsp. bulgaricus, Lactobacillus acidophilus, Lactobacillus plantarum, Lactiplantibacillus plantarum, Lactobacillus brevis, Lactobacillus helveticus, and Bifidobacterium [pg. 5, lines 10-25; pg. 12, lines 13-30; Claims 1-3]. Agayn discloses that the method preferably includes treating the grain with an amylase (carbohydrase) before fermenting the grain [pg. 16, lines 24-30; pg. 17, lines 1-16]. Agayn discloses that a protease can be used in the method [pg. 51, lines 11-15]. Agayn discloses that proteases help make available starches for degradation while degrading proteins [pg. 51, lines 11-15]. It is known in the art that at least oats, rice, fonio, millet and corn (maize) are gluten free grains and therefore the method would have produced a gluten free product. Agayn discloses that the enzymatic treatment step occurs at temperature optimal for amylase at lower than 60°C; lower than 50°C; at 40-80°C [pg. 17, lines 5-11]. Agayn discloses fermenting until a desired pH is reached, for example between 3.8 and 5.5 [pg. 50, lines 24-29]. However, Agayn does not disclose the length of time for fermentation. Mok discloses a method of making rice yogurt [abstract]. Mok discloses fermenting with L. bulgaricus for 15 to 30 hours [abstract]. Mok also discloses fermenting with L. acidophilus, L. plantarum [pg. 3]. Mok discloses the formation of desirable flavors and taste [abstract]. Mok discloses achieving a described level of acidity [pg. 3]. At the effective filing date of the invention, it would have been obvious to one of ordinary skill in the art to modify the method of Agayn to include fermenting for 15-30 hours as in Mok since it discloses fermenting with lactic acid bacteria reaching a desired level or sourness and acidity. It would have been obvious to ferment the cereal grain of Agayn for 15-30 hours since it’s grains would be able to reach a high level of acidity in that time frame. Alternatively, although Agayn does not explicitly disclose from about 25 to about 60°C one having ordinary skill in the art at the effective filing date of the invention would have considered the invention to have been obvious because the range taught by Agayn overlaps the instantly claimed range and therefore is considered to establish a prima facie case of obviousness. In re Malagari 182 USPQ 549,553. Alternatively, although Mok does not explicitly disclose from about 1 to about 2 days one having ordinary skill in the art at the effective filing date of the invention would have considered the invention to have been obvious because the range taught by Mok overlaps the instantly claimed range and therefore is considered to establish a prima facie case of obviousness. In re Malagari 182 USPQ 549,553. Regarding Claim 2: Agayn discloses as discussed above in claim 1. Agayn discloses that the cereal is in the form of flour [pg. 9, lines 29 and 30; pg. 48, lines 8-10]. Regarding Claims 6 and 7: Agayn discloses as discussed above in claim 1. Agayn discloses that the treating step can occur before fermenting the grain [pg. 16, lines 24-30; pg. 17, lines 1-16]. Regarding Claim 8: Agayn discloses as discussed above in claim 1. Agayn discloses that the starch containing grain is heated to between 80 to 120°C [pg. 9, lines 17-19; claim 11]. Regarding Claim 9: Agayn discloses as discussed above in claim 1. Agayn discloses that the grain can be oat [pg. 5, lines 10-15; pg. 6, lines 1-2]. Regarding Claim 11: Agayn discloses as discussed above in claim 1. Agayn discloses fermenting the grains with lactic acid bacteria such as Lactobacillus paracasei, Lactobacillus casei, Lactobacillus rhamnosus, Lactobacillus bulgaricus, Lactobacillus delbrueckii subsp. bulgaricus, Lactobacillus acidophilus, Lactobacillus plantarum, Lactiplantibacillus plantarum, Lactobacillus brevis, Lactobacillus helveticus, and Bifidobacterium [pg. 5, lines 10-25; pg. 12, lines 13-30; Claims 1-3]. Regarding Claim 19: Agayn discloses as discussed above in claim 1. Agayn discloses mixing oat flour and water with the enzymes. This is essentially oat milk as it is known in the art to make oat milk from ground oats, and water and amylase. Response to Arguments The 103(a) rejections of claims 1, 2, 4, 6-9, 11, and 19 over Agayn (WO 2017/126959) and in further view of Bhowmik et al. (WO 2020/157209). The 103(a) rejection of claim 20 is rejected under 35 U.S.C. 103 as being unpatentable over Agayn (WO 2017/126959), Bhowmik et al. (WO 2020/157209) and DeSimone et al. (US 2008/0131556) has been withdrawn due to the cancellation of the claim. Pertinent Prior Art The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Oikarinen et al. (FI 20176171) pub June 23, 2019 Oikarinen discloses a method of making a plant based food or drinkable product [abstract]. Oikarinen discloses treatment of enzymes at 5 to 95°C; and 50 to 70°C [pg. 7, lines 20-27; pg. 8, lines 7 and 8]. Oikarinen discloses that the plant based material can be derived from oats and corn [pg. 10, lines 12-16]. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to FELICIA C TURNER whose telephone number is (571)270-3733. The examiner can normally be reached Mon-Thu 8:00-4:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Emily Le can be reached at 571-272-0903. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Felicia C Turner/Primary Examiner, Art Unit 1793
Read full office action

Prosecution Timeline

Dec 15, 2023
Application Filed
Mar 09, 2026
Non-Final Rejection mailed — §103
Jun 09, 2026
Response Filed
Aug 31, 2026
Final Rejection mailed — §103
Sep 10, 2026
Response after Non-Final Action
Sep 23, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12727604
A PROCESS FOR PREPARING A BEVERAGE ENRICHED WITH NATURAL ANTIOXIDANTS AND BEVERAGE COMPOSITION THEREOF
2y 5m to grant Granted Sep 08, 2026
Patent 12714120
BIOPROTECTIVE LACTIC ACID BACTERIA WITH LOW POSTACIDIFICATION
3y 9m to grant Granted Aug 25, 2026
Patent 12690602
TRADITIONAL CHINESE MEDICINE POLYSACCHARIDE EXTRACT FREEZE-DRYING PROTECTIVE AGENT, DIRECT-TO-VAT STARTER AND PREPARATION METHODS THEREOF
3y 6m to grant Granted Jul 28, 2026
Patent 12642280
YEAST AND LACTIC ACID BACTERIA COMBINATION
3y 7m to grant Granted Jun 02, 2026
Patent 12628834
A BREAD WITH D-ALLULOSE INSTEAD OF SUCROSE AND A PREPARATION METHOD THEREFOR
2y 10m to grant Granted May 19, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
26%
Grant Probability
56%
With Interview (+30.1%)
4y 2m (~1y 4m remaining)
Median Time to Grant
High
PTA Risk
Based on 636 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month